Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary indicates solid financial performance with increased core operating margin and strong EPS growth. The Q&A revealed management's confidence in leadership transition, strategic restructuring, and innovation plans. Although there are challenges like tariffs and slower category growth, P&G's proactive strategies and shareholder returns are likely to have a positive impact. The overall sentiment is positive, but not strong, due to uncertainties in guidance and market conditions.
Organic Sales Growth 2% for the year, with volume growth contributing 1 point and price/mix adding 1 point. Growth was broad-based across categories and regions, with 9 out of 10 product categories growing. Baby Care was the only category down, with low single-digit decline. Reasons include volatile macroeconomic, geopolitical, and consumer dynamics.
Earnings Per Share (EPS) $6.83, up 4% for the year. Core gross margin declined 40 basis points, while core operating margin increased 50 basis points. Productivity improvements of nearly $2.7 billion enabled increased investment in superior products and brand communication.
Free Cash Flow Productivity 87% for the year. The company returned $16 billion to shareholders, including nearly $10 billion in dividends and $6.5 billion in share repurchases.
E-commerce Sales Increased 12%, now representing 19% of total company sales. This growth reflects the shift in consumer purchasing behavior towards online platforms.
Core Operating Margin Increased 50 basis points for the year, supported by $2.7 billion in productivity improvements across cost of goods sold and SG&A.
Fourth Quarter Organic Sales Growth 2%, with volume in line with the prior year and pricing/mix each up 1%. Growth was broad-based across categories and regions, with 9 out of 10 product categories holding or growing organic sales. Baby Care was the only category down, with low single-digit decline.
Fourth Quarter Core EPS $1.48, up 6% versus the prior year. On a currency-neutral basis, core EPS increased 5%. These results include a $0.03 impact from tariffs.
Fourth Quarter Free Cash Flow Productivity 110%. The company returned $3.3 billion to shareholders, including $2.6 billion in dividends and $700 million in share repurchases.
Pampers in China: Pampers grew organic sales nearly 20% in China and increased value share by over 2 points, becoming the best diaper for newborns among moms under 30.
SK-II LXP: Launched a supercharged product line with the highest concentration of PITERA, positioned in the super-premium segment, driving brand equity and growth in China.
Pantene in Latin America: Pantene's deep conditioning treatment collection led category growth in Mexico, with organic sales up mid-teens and value share growth over 1.5 points.
Swiffer Sweep and Mop Deluxe: Introduced a sturdier stick with 2-in-1 cleaning capabilities, achieving 6% new users and 30% incremental sales to the Swiffer Sweeper starter kit business.
Align digestive wellness: Launched new products addressing bloating and digestion, accelerating share growth with innovative 3-in-1 Biotic.
Tide evo: Developed a new laundry detergent with superior cleaning performance in a recyclable package, showing high incremental sales in test markets.
E-commerce growth: E-commerce sales increased 12%, now representing 19% of total company sales.
Regional performance: Focus Markets grew organic sales 2%, with North America up 2% and Europe Focus Markets up 3%. Greater China improved sequentially, growing 2% in the most recent quarter.
Enterprise Markets: Enterprise Markets grew 3%, led by Latin America with 6% organic sales growth in the quarter, including double-digit growth in Mexico.
Productivity improvements: Achieved nearly $2.7 billion in productivity improvements across cost of goods sold and SG&A, enabling increased investment in superior products and brand communication.
Restructuring program: Announced a 2-year restructuring program focusing on portfolio simplification, supply chain optimization, and organization design, including reducing up to 7,000 non-manufacturing roles.
Portfolio adjustments: Streamlining product lines in Feminine Care, Oral Care, Fabric Care, and Grooming in Asia and discontinuing operations in Bangladesh to focus on higher-value opportunities.
Innovation superiority: Focused on integrated superiority across product, package, brand communication, retail execution, and value to drive market growth and share gains.
Macroeconomic and Geopolitical Volatility: The company faced volatile macroeconomic, geopolitical, and consumer dynamics, resulting in market-level headwinds that were not anticipated at the start of the fiscal year. This includes heightened consumer anxiety with tariffs, inflation, interest rates, political and social divisiveness, and immigration and employment status uncertainty.
Tariffs and Trade Barriers: The company expects $1 billion in higher costs from tariffs in fiscal '26, including impacts from materials and products imported from China, Canada, and other regions. Tariffs alone are a 5-point headwind to core EPS growth.
Market Growth and Consumer Confidence: Lower category growth and unpredictable geopolitical environments have impacted market growth. Economic and consumer confidence impacts, particularly in Greater China, are being closely monitored.
Restructuring Program Risks: The company announced a 2-year restructuring program, including portfolio simplifications, supply chain adjustments, and workforce reductions of up to 7,000 nonmanufacturing roles. These changes may pose execution risks and potential disruptions.
Supply Chain and Cost Pressures: The company faces ongoing supply chain challenges, including rightsizing and right-locating production to drive efficiencies and cost reductions. Commodity cost headwinds of approximately $200 million after tax are also expected.
Competitive Pressures: The company operates in a highly competitive environment with capable competitors, requiring continuous innovation and execution to maintain market share.
Organic Sales Growth: Guidance for organic sales growth is in the range of flat to up 4% for fiscal year 2026. This includes a 30 to 50 basis point headwind from brand and product form discontinuations as part of the 2-year restructuring program.
Core EPS Growth: Guidance for core EPS growth is in the range of flat to up 4%, equating to $6.83 to $7.09 per share for fiscal year 2026. The midpoint of the range is $6.96, representing a 2% increase.
Market Growth Expectations: The markets in which P&G competes are expected to deliver local currency value growth in the range of flat to 3% for fiscal year 2026. P&G aims to grow organic sales modestly ahead of this underlying market growth.
Tariff Impact: Fiscal year 2026 includes a $1 billion before-tax headwind from tariffs, equating to a 5-point headwind to core EPS growth. This includes tariffs on goods imported from China, Canada, and other regions.
Free Cash Flow Productivity: Adjusted free cash flow productivity is forecasted in the range of 85% to 90% for fiscal year 2026, including increased capital spending and restructuring costs.
Capital Return to Shareholders: P&G plans to return approximately $15 billion to shareholders in fiscal year 2026, including $10 billion in dividends and $5 billion in share repurchases.
Restructuring Program: The 2-year restructuring program includes portfolio simplifications, supply chain adjustments, and organizational changes. Up to 7,000 non-manufacturing roles will be reduced, representing 15% of the current non-manufacturing workforce.
Dividend Increase: We increased our dividend by 5% and returned $16 billion of value to shareowners, nearly $10 billion in dividends.
Dividend Payment in Q4: We returned $3.3 billion of cash to shareowners this quarter, $2.6 billion in dividends.
Share Repurchase Program: We returned $16 billion of value to shareowners, including $6.5 billion in share repurchase, consistent with our guidance at the start of the fiscal year.
Share Repurchase in Q4: We returned $3.3 billion of cash to shareowners this quarter, including $700 million in share repurchase.
The earnings call summary presents a mixed outlook. Basic financial performance, product development, and market strategy sections show moderate optimism, with growth expected in the second half of the year. However, concerns about margin trajectory, grooming segment weakness, and the lack of specific guidance on growth balance indicate uncertainties. The shareholder return plan is positive, but overall, the combination of positive and negative factors results in a neutral sentiment, suggesting limited stock price movement.
The earnings call reveals strong growth in key regions like China and Latin America, with effective restructuring and innovation strategies. Despite a slight market share decline, positive trends in the U.S. and strategic responses to competition suggest resilience. The Q&A highlights management's focus on innovation and value, with optimistic guidance in North America and Latin America. However, concerns over competition and market volatility in China are noted. Overall, the positive aspects outweigh negatives, indicating a likely stock price increase.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.